TrialJournal of hematology & oncology2024

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

Marion Alcantara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.